PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business. The image analysis algorithms will be deployed on Roche's...

Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...

You are invited to our next complimentary webinar – March 28, 2018 Almost 200 years ago a new technology, the microscope, revolutionized the way in which medicine was practiced, resulting in the invention of Surgical Pathology as a...

April 16, 2015, Westminster CO — Flagship Biosciences, the leading service provider of digital pathology solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope®...

Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology Boulder, CO - April 30, 2014 - Flagship Biosciences announces it has reached agreement with Leica...

Enzo Biochem and Flagship Biosciences partner to provide tissue-based companion diagnostics offering complete solution for in situ hybridization development to pharmaceutical companies New York, NY – December 11, 2013 - Enzo Biochem Inc....